Comparison Between Single and Triple Rubber Band Ligation for the Treatment of Hemorrhoids
NCT ID: NCT01383577
Last Updated: 2013-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
76 participants
INTERVENTIONAL
2010-03-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients enrolled in the study, after applying inclusion and exclusion criteria, signed the consent form, and responded to a questionaire about epidemiological data and hemorrhoidal symptoms, are (and will be) randomly allocated to one of the two arms of the study: G1: a single major hemorrhoidal group is ligated in each of three sessions of hemorrhoidal ligation, while the two other hemorrhoidal groups are submitted to sham ligation (a McGown aspirating type of hemorrhoidal ligator is employed); G2: all three major hemorrhoidal groups are ligated in the first session of treatment and in the next two sessions only sham ligations are performed. Three sessions of hemorrhoidal and/or sham ligation are performed in all patients, each spaced by one month from the other. A final consultation is held 1 month after the third ligation session in order to gather all the results of the treatment.
After each session of hemorrhoidal ligation patients receive a chart containing a modified level of pain scale (Wong \& Baker) and are asked to indicate pain level (from 0 to 5: 0 = no pain, 5 = unbearable pain) at fixed intervals (immediate post-ligation, 12 h post-ligation, 24 h post-ligation and each other day until 7 days post-ligation). Investigators gather this information about pain, and patient well-being post-ligations, from 8 programmed telephone calls to the patients after each session of hemorrhoidal (or sham) ligation.
Three months after the first session of hemorrhoidal ligation all patients are examined in order to observe treatment effectiveness and gather data about complications, patient satisfaction, number of days of occupational absenteeism linked to each session of treatment and number of analgesic pills necessary for pain relief.
Comparative costs of each modality of ligation are raised taking into consideration the salaries of health professionals involved in the treatment, the salaries of the patients (calculation of absenteeism), the value of consumables used in each session of effective ligation, the depreciation price of permanent material employed and the price of medications patients have to buy.
Patients are blinded to the modality of hemorrhoidal ligation employed and the statistician does not know the nature of each treatment group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single hemorrhoidal ligation
Effective ligation of one hemorrhoidal group and sham ligation of the two other major hemorrhoidal groups is performed in each session of treatment.
Single hemorrhoidal ligation
Effective ligation of one hemorrhoidal group and sham ligation of the two other major hemorrhoidal groups is performed in each of three sessions of treatment. Final revision is performed 90 days after first session of hemorrhoidal ligation.
Triple hemorrhoidal ligation
The three major hemorrhoidal groups are ligated in the first session of ligation. The three following monthly appointments of patients of this arm are for sham hemorrhoidal ligations and final revision.
Triple hemorrhoidal ligation
The three major hemorrhoidal groups are ligated in the first session of ligation. Sham triple hemorrhoidal ligations are performed 30 and 60 days after the first session. Final revision is done 90 days after first ligation session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single hemorrhoidal ligation
Effective ligation of one hemorrhoidal group and sham ligation of the two other major hemorrhoidal groups is performed in each of three sessions of treatment. Final revision is performed 90 days after first session of hemorrhoidal ligation.
Triple hemorrhoidal ligation
The three major hemorrhoidal groups are ligated in the first session of ligation. Sham triple hemorrhoidal ligations are performed 30 and 60 days after the first session. Final revision is done 90 days after first ligation session.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Immunodepression
* Indians
* Infectious, inflammatory or tumoral anorectal comorbidities
* Previous anorectal surgeries
* Patients on anticoagulant therapy or with coagulation disorders
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Amazonas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivan Tramujas da Costa e Silva
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan T Costa e Silva, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Amazonas
Érico L Melo, Med Grad
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Giselle L Afonso, Med Grad
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Felicidad S Gimenez, MSc
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Shymmene O Cardoso, BAccount
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Daniel Richard M Mota, Med Grad
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Rachel M Carvalho, Med Grad
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Saskia Regina F Coppens, Med Grad
Role: STUDY_CHAIR
Universidade Federal do Amazonas
Themis C Abensur, MSc
Role: STUDY_CHAIR
Federal University of Amazonas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitário Getúlio Vargas - Ambulatório Araújo Lima
Manaus, Amazonas, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PP-S/0001/2010
Identifier Type: -
Identifier Source: org_study_id